Across TCGA pan-cancer cohorts, MIR1290 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR1290 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR1290 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR1290 expression acts as an unfavorable survival marker, although some lineages such as LAML and BLCA show a favorable association.
UCEC, SKCM, and THYM are the cancer types where MIR1290 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.